A Study That Looks at the Function of the Heart in Patients With Heart Failure Who Take Empagliflozin

NCT03332212 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Empagliflozin
DRUG: Placebo

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]